Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Articles
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Innovation
392 Articles Available
1
17
Can't find what you're looking for? Try our
advanced search
.
Enpoint
Lilly's CYRAMZA® Phase 3 RELAY Trial Met Primary Endpoint in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
PR-M03-19-NI-039
Assay
ForteBio Introduces New Product for High-Throughput Glycan Screening
PR-M03-19-NI-036
Investment in Innovation
How Agile Investment Drives Innovation
PAP-Q1-2019-CL-004
Form-Fill-Seal
Investing in Form-Fill-Seal Technology
PAP-Q1-2019-CL-011
Cell and Gene Therapy
Driving Growth of the Cell and Gene Therapy Sector
PAP-Q1-2019-CL-012
Virtual Panel
Reprioritizing to Bring FY2020 into Focus
PAP-Q1-2019-CL-032
Global Partner
A World-Class Partner for Today’s Market
PAP-Q1-2019-CL-039
Artificial Intelligence
Pharma Makes Moves to Leverage Artificial Intelligence
PAP-Q1-2019-NI-006
Innovation
FDA Releases Final Classification for Natural Cycles, the First and Only Birth Control App in the U.S.
PR-M03-19-NI-031
Drug Pricing
How Do You Classify Fecal Microbiota?
PAO-M03-19-NI-012
Innovation
Innovative Tech Might Make Infrared Vision Possible
PAO-M03-19-NI-010
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D. on New Programs to Promote the Adoption of Innovations in Drug Manufacturing
PR-M02-19-NI-034
Research
Researchers May Have Found Method for Detecting Consciousness
PAO-M02-19-NI-012
Oral Insulin
An Innovative Approach to Oral Insulin
PAO-M02-19-NI-010
Innovation
Phillips-Medisize Named Winner of 2019 Pharmapack Innovation Award: Best Innovation in Drug Delivery
PR-M02-19-NI-024
Drug Development
Bio-Techne Introduces CE-SDS PLUS for Maurice™ System
PR-M01-19-NI-083
Oncology
The EVA System Colposcope Fulfills Promise of the AVE Algorithm to Change Future of Cervical Cancer Detection
PR-M01-19-NI-038
Innovation
Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients
PR-M12-18-NI-042
Facility
WuXi Biologics Breaks Ground on Innovation Center in China
PAO-M11-18-NI-026
Newly Published Feeding Trial Showed Cranberries Reduced the Negative Impact of a Low Fiber, Animal-Based Diet on Gut Health
PR-M11-18-NI-054
Innovation
A new PD-L1 BOND Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need
PR-M11-18-NI-050
Novel Therapy
Novel Combination Therapy Promotes Wound Healing
PR-M10-18-NI-096
Roundtable
Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?
PAP-Q4-18-NI-007
Roundtable
Q: Looking Forward, What New Technologies/Paradigms Do You Anticipate Having the Greatest Impact Next Year (Digitalization and Industry 4.0, Serialization, etc.)?
PAP-Q4-18-NI-003
1
17
»
